The PGC-1 cascade as a therapeutic target for heart failure

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 4, 2011, Pages 578-583

  Schilling, Joel ^a   Kelly, Daniel P ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Diabetes; Estrogen related receptor (ERR); Heart failure; Metabolism; PPAR coactivator 1 (PGC 1)

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL NUCLEUS RECEPTOR; ESTROGEN RELATED RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR GAMMA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; RESVERATROL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DRUG TARGETING; ENERGY METABOLISM; GENE CONTROL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE METABOLISM; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEART; HEART FAILURE; HUMANS; MOLECULAR TARGETED THERAPY; MYOCARDIUM; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 80052812434     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.09.021     Document Type: Review

References (70)

1. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell Mar 20 1998, 92(6):829-839.
2. Lin J., Puigserver P., Donovan J., Tarr P., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem Jan 18 2002, 277(3):1645-1648.
3. Huss J.M., Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res Sep 17 2004, 95(6):568-578.
4. Finck B.N., Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation May 15 2007, 115(19):2540-2548.
5. Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab Jun 2005, 1(6):361-370.
6. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell Jul 9 1999, 98(1):115-124.
7. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Investig Oct 2000, 106(7):847-856.
8. Goto M., Terada S., Kato M., Katoh M., Yokozeki T., Tabata I., et al. cDNA cloning and mRNA analysis of PGC-1 in epitrochlearis muscle in swimming-exercised rats. Biochem Biophys Res Commun Aug 2 2000, 274(2):350-354.
9. Handschin C., Rhee J., Lin J., Tarr P.T., Spiegelman B.M. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci USA Jun 10 2003, 100(12):7111-7116.
10. Schaeffer P.J., Wende A.R., Magee C.J., Neilson J.R., Leone T.C., Chen F., et al. Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle. J Biol Chem Sep 17 2004, 279(38):39593-39603.
11. Rohas L.M., St-Pierre J., Uldry M., Jager S., Handschin C., Spiegelman B.M. A fundamental system of cellular energy homeostasis regulated by PGC-1alpha. Proc Natl Acad Sci USA May 8 2007, 104(19):7933-7938.
12. Zong H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum M.J., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci USA Dec 10 2002, 99(25):15983-15987.
13. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science Feb 7 2003, 299(5608):896-899.
14. Czubryt M.P., McAnally J., Fishman G.I., Olson E.N. Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA Feb 18 2003, 100(4):1711-1716.
15. Sonoda J., Laganiere J., Mehl I.R., Barish G.D., Chong L.W., Li X., et al. Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense. Genes Dev Aug 1 2007, 21(15):1909-1920.
16. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab Jul 2006, 4(1):13-24.
17. Canto C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol Apr 2009, 20(2):98-105.
18. Puigserver P., Rhee J., Lin J., Wu Z., Yoon J.C., Zhang C.Y., et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell Nov 2001, 8(5):971-982.
19. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA Jul 17 2007, 104(29):12017-12022.
20. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature Apr 23 2009, 458(7241):1056-1060.
21. Kelly T.J., Lerin C., Haas W., Gygi S.P., Puigserver P. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation. J Biol Chem Jul 24 2009, 284(30):19945-19952.
22. Zhang Y., Huypens P., Adamson A.W., Chang J.S., Henagan T.M., Boudreau A., et al. Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J Biol Chem Nov 20 2009, 284(47):32813-32826.
23. Chang JS, Huypens P, Zhang Y, Black C, Kralli A, Gettys TW. Regulation of NT-PGC-1alpha subcellular localization and function by protein kinase A-dependent modulation of nuclear export by CRM1. The Journal of Biological Chemistry, Jun 4 2003; 285(23): 18039-50.
24. Giguere V., Yang N., Segui P., Evans R.M. Identification of a new class of steroid hormone receptors. Nature Jan 7 1988, 331(6151):91-94.
25. Huss J.M., Kopp R.P., Kelly D.P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem Oct 25 2002, 277(43):40265-40274.
26. Kamei Y., Ohizumi H., Fujitani Y., Nemoto T., Tanaka T., Takahashi N., et al. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA Oct 14 2003, 100(21):12378-12383.
27. Rangwala S.M., Li X., Lindsley L., Wang X., Shaughnessy S., Daniels T.G., et al. Estrogen-related receptor alpha is essential for the expression of antioxidant protection genes and mitochondrial function. Biochem Biophys Res Commun May 25 2007, 357(1):231-236.
28. Lai L., Leone T.C., Zechner C., Schaeffer P.J., Kelly S.M., Flanagan D.P., et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev Jul 15 2008, 22(14):1948-1961.
29. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell Oct 1 2004, 119(1):121-135.
30. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 2005 Apr, 3(4):e101.
31. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab Apr 2005, 1(4):259-271.
32. Lehman J.J., Boudina S., Banke N.H., Sambandam N., Han X., Young D.M., et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol Jul 2008, 295(1):H185-H196.
33. Lelliott C.J., Medina-Gomez G., Petrovic N., Kis A., Feldmann H.M., Bjursell M., et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol Nov 2006, 4(11):e369.
34. Vianna C.R., Huntgeburth M., Coppari R., Choi C.S., Lin J., Krauss S., et al. Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab Dec 2006, 4(6):453-464.
35. Sonoda J., Mehl I.R., Chong L.W., Nofsinger R.R., Evans R.M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA Mar 20 2007, 104(12):5223-5228.
36. Russell L.K., Mansfield C.M., Lehman J.J., Kovacs A., Courtois M., Saffitz J.E., et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res Mar 5 2004, 94(4):525-533.
37. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell Oct 20 2006, 127(2):397-408.
38. Alaynick W.A., Kondo R.P., Xie W., He W., Dufour C.R., Downes M., et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab Jul 2007, 6(1):13-24.
39. Huss J.M., Torra I.P., Staels B., Giguere V., Kelly D.P. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol Oct 2004, 24(20):9079-9091.
40. Taegtmeyer H., Golfman L., Sharma S., Razeghi P., van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann NY Acad Sci May 2004, 1015:202-213.
41. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev Jul 2005, 85(3):1093-1129.
42. de las Fuentes L., Herrero P., Peterson L.R., Kelly D.P., Gropler R.J., Davila-Roman V.G. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension Jan 2003, 41(1):83-87.
43. Huss J.M., Imahashi K., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., et al. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab Jul 2007, 6(1):25-37.
44. Young M.E., Laws F.A., Goodwin G.W., Taegtmeyer H. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem Nov 30 2001, 276(48):44390-44395.
45. Ingwall J.S., Kramer M.F., Fifer M.A., Lorell B.H., Shemin R., Grossman W., et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985, 313(17):1050-1054.
46. Bottomley P.A., Wu K.C., Gerstenblith G., Schulman S.P., Steinberg A., Weiss R.G. Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation April 14 2009, 119(14):1918-1924.
47. Gupta A., Chacko V.P., Weiss R.G. Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance. Am J Physiol Heart Circ Physiol July 1 2009, 297(1):H59-H64.
48. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci USA Jun 27 2006, 103(26):10086-10091.
49. Davila-Roman V.G., Vedala G., Herrero P., de las Fuentes L., Rogers J.G., Kelly D.P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol Jul 17 2002, 40(2):271-277.
50. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation Dec 1 1996, 94(11):2837-2842.
51. Sihag S., Cresci S., Li A.Y., Sucharov C.C., Lehman J.J. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol Feb 2009, 46(2):201-212.
52. Koitabashi N., Bedja D., Zaiman A.L., Pinto Y.M., Zhang M., Gabrielson K.L., et al. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res Jul 2 2009, 105(1):12-15.
53. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation May 11 2004, 109(18):2191-2196.
54. Herrero P., Peterson L.R., McGill J.B., Matthew S., Lesniak D., Dence C., et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol Feb 7 2006, 47(3):598-604.
55. Buchanan J., Mazumder P.K., Hu P., Chakrabarti G., Roberts M.W., Yun U.J., et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology Dec 2005, 146(12):5341-5349.
56. Duncan J.G., Fong J.L., Medeiros D.M., Finck B.N., Kelly D.P. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation Feb 20 2007, 115(7):909-917.
57. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J Nov 2004, 18(14):1692-1700.
58. Brookheart R.T., Michel C.I., Schaffer J.E. As a matter of fat. Cell Metab Jul 2009, 10(1):9-12.
59. Wende A.R., Schaeffer P.J., Parker G.J., Zechner C., Han D.H., Chen M.M., et al. A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J Biol Chem Dec 14 2007, 282(50):36642-36651.
60. Elkayam U., Tasissa G., Binanay C., Stevenson L.W., Gheorghiade M., Warnica J.W., et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J Jan 2007, 153(1):98-104.
61. Lee W.J., Kim M., Park H.S., Kim H.S., Jeon M.J., Oh K.S., et al. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun Feb 3 2006, 340(1):291-295.
62. Eurich D.T., McAlister F.A., Blackburn D.F., Majumdar S.R., Tsuyuki R.T., Varney J., et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (Clinical research ed.) Sep 8 2007, 335(7618):497.
63. Sasaki H., Asanuma H., Fujita M., Takahama H., Wakeno M., Ito S., et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation May 19 2009, 119(19):2568-2577.
64. Gundewar S., Calvert J.W., Jha S., Toedt-Pingel I., Ji S.Y., Nunez D., et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res Feb 13 2009, 104(3):403-411.
65. Elliott P.J., Jirousek M. Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs Apr 2008, 9(4):371-378.
66. Chen C.J., Yu W., Fu Y.C., Wang X., Li J.L., Wang W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem Biophys Res Commun Jan 16 2009, 378(3):389-393.
67. Lin J.F., Lin S.M., Chih C.L., Nien M.W., Su H.H., Hu B.R., et al. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci Aug 29 2008, 83(9-10):313-317.
68. Thirunavukkarasu M., Penumathsa S.V., Koneru S., Juhasz B., Zhan L., Otani H., et al. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med Sep 1 2007, 43(5):720-729.
69. Rangwala S.M., Wang X., Calvo J.A., Lindsley L., Zhang Y., Deyneko G., et al. Estrogen-related receptor γ is a key regulator of muscle mitochondrial activity and oxidative capacity. J Biol Chem July 16 2010, 285(29):22619-22629.
70. Yang J., Williams R.S., Kelly D.P. Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha to coactivate nuclear receptors estrogen-related receptor alpha and PPARalpha. Mol Cell Biol Aug 2009, 29(15):4091-4102.